
Pfizer to launch trial of Omicron-targeted COVID vaccine
The company has said that two doses of the original vaccine may not be sufficient to protect against infection from Omicron.
Full Article
The company has said that two doses of the original vaccine may not be sufficient to protect against infection from Omicron.
Full ArticleDel Bigtree, Aaron Siri and The Highwire report on the heartbreaking story of Maddie de Garay, who was seriously injured by the..
Watch VideoThe European Medicines Agency has recommended that Pfizer's coronavirus antiviral drug be authorized for use in the..